Smith & Nephew plc (SNN)
NYSE: SNN · Real-Time Price · USD
28.34
+0.01 (0.04%)
At close: May 9, 2025, 4:00 PM
28.34
0.00 (0.00%)
After-hours: May 9, 2025, 7:00 PM EDT
Smith & Nephew Revenue
In the year 2024, Smith & Nephew had annual revenue of $5.81B with 4.70% growth. Smith & Nephew had revenue of $2.98B in the half year ending December 31, 2024, with 14.07% growth.
Revenue (ttm)
$5.81B
Revenue Growth
+4.70%
P/S Ratio
2.14
Revenue / Employee
$321,705
Employees
18,060
Market Cap
12.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
| Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
| Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
| Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
| Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
SNN News
- 2 days ago - Study shows patients treated with Smith+Nephew's CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹* - GlobeNewsWire
- 4 days ago - Smith+Nephew to showcase its CORI™ Surgical System at surgical clinics across Germany, Austria and Switzerland - GlobeNewsWire
- 7 days ago - Smith & Nephew plc (SNN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 19 days ago - Smith & Nephew: Underappreciated Recovery With Strategic Upside - Seeking Alpha
- 5 weeks ago - Trump tariffs: these two European healthcare stocks face the highest US revenue exposure - Invezz
- 2 months ago - Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025 - GlobeNewsWire
- 2 months ago - Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025 - GlobeNewsWire
- 2 months ago - New report confirms Smith+Nephew's OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty - GlobeNewsWire